Trials / Completed
CompletedNCT01387620
Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2%
Intraindividual Randomized Clinical Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2% in Phacoemulsification
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This prospective study was performed to compare two ophthalmic viscosurgical devices, DisCoVisc (hyaluronic acid 1.6% - chondroitin sulfate 4.0%) and hydroxypropylmethylcellulose 2% in terms of their overall clinical performance during phacoemulsification.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyaluronic Acid and hydroxypropylmethylcellulose | Hyaluronic Acid 1.6% was used to performed phacoemulsification in one eye and hydroxypropylmethylcellulose 2% was used in the fellow eye. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-02-01
- Completion
- 2010-12-01
- First posted
- 2011-07-04
- Last updated
- 2011-07-04
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01387620. Inclusion in this directory is not an endorsement.